BioNexus Gene Lab Income Taxes 2019-2024 | BGLC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioNexus Gene Lab income taxes from 2019 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioNexus Gene Lab income taxes from 2019 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$120.6B
Cencora (COR)	$44.1B
ICON (ICLR)	$23.6B
DiDi Global (DIDIY)	$22.4B
Avantor (AVTR)	$17.7B
Revvity (RVTY)	$15.6B
Natera (NTRA)	$15.3B
Viatris (VTRS)	$13.9B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$11.8B
Charles River Laboratories (CRL)	$10.2B
Medpace Holdings (MEDP)	$10.1B
Sonic Healthcare (SKHHY)	$9.1B
Doximity (DOCS)	$7.9B
HealthEquity (HQY)	$6.9B
Bausch + Lomb (BLCO)	$6.7B
PACS (PACS)	$6B
Organon (OGN)	$4.9B
Life Times (LTH)	$4.9B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.1B
Concentras Parent (CON)	$2.9B
Ardent Health Partners (ARDT)	$2.7B
GoodRx Holdings (GDRX)	$2.5B
BrightSpring Health Services (BTSG)	$2.5B
Alignment Healthcare (ALHC)	$2.1B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$2B
AMN Healthcare Services Inc (AMN)	$1.6B
CareDx (CDNA)	$1.6B